273 related articles for article (PubMed ID: 16412993)
1. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
Kira Y; Nishikawa M; Ochi A; Sato E; Inoue M
Brain Res; 2006 Jan; 1070(1):206-14. PubMed ID: 16412993
[TBL] [Abstract][Full Text] [Related]
2. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
3. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
4. Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis.
Deitch JS; Alexander GM; Bensinger A; Yang S; Jiang JT; Heiman-Patterson TD
PLoS One; 2014; 9(6):e99879. PubMed ID: 24945277
[TBL] [Abstract][Full Text] [Related]
5. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
[TBL] [Abstract][Full Text] [Related]
7. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
8. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
9. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Andrus PK; Fleck TJ; Gurney ME; Hall ED
J Neurochem; 1998 Nov; 71(5):2041-8. PubMed ID: 9798929
[TBL] [Abstract][Full Text] [Related]
10. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
11. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.
Zhang B; Tu P; Abtahian F; Trojanowski JQ; Lee VM
J Cell Biol; 1997 Dec; 139(5):1307-15. PubMed ID: 9382875
[TBL] [Abstract][Full Text] [Related]
12. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
13. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
Chi L; Ke Y; Luo C; Gozal D; Liu R
Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
Wong M; Martin LJ
Hum Mol Genet; 2010 Jun; 19(11):2284-302. PubMed ID: 20223753
[TBL] [Abstract][Full Text] [Related]
15. Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis.
Shimojo Y; Kosaka K; Noda Y; Shimizu T; Shirasawa T
J Neurosci Res; 2010 Mar; 88(4):896-904. PubMed ID: 19798750
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
17. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
18. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
Nakano R
Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.
Wang L; Gutmann DH; Roos RP
Hum Mol Genet; 2011 Jan; 20(2):286-93. PubMed ID: 20962037
[TBL] [Abstract][Full Text] [Related]
20. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Hegedus J; Putman CT; Gordon T
Neurobiol Dis; 2007 Nov; 28(2):154-64. PubMed ID: 17766128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
